Трансплантология (Москва) (Aug 2018)

Hepatopulmonary syndrome

  • V. T. Ivashkin,
  • M. A. Morozova,
  • M. V. Mayevskaya

DOI
https://doi.org/10.23873/2074-0506-2009-0-2-5-8
Journal volume & issue
Vol. 0, no. 2
pp. 5 – 8

Abstract

Read online

The purpose of this paper is to analyze the data available in the literature on the problems associated with the identification of the hepatopulmonary syndrome (HPS), its diagnosis, pathogenesis, clinical features, and possible treatment options. According to the current literature, HPS is a complication of liver diseases, which leads to impaired lung perfusion and decreased blood oxygenation. Recognition of this syndrome requires that there should be a triad of the following signs: chronic liver disease, dilated intrapulmonary vessels, and lower arterial blood oxygenation. Today investigators' views of the causes and pathogenesis of dilated pulmonary vessels and abnormal blood gas composition differ in HPS. To date, its clear diagnostic algorithm and treatment policy for patients with HPS have not been elaborated.

Keywords